SC 13G Filing

Company

BIOMARIN PHARMACEUTICAL INC

Filed

September 30, 2024

Accession Number

0000905148-24-002591

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →